JMP Securities Maintains Market Outperform on Prothena Corp, Raises Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jason Butler has maintained a Market Outperform rating on Prothena Corp (NASDAQ:PRTA) and increased the price target from $81 to $85.
February 16, 2024 | 7:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has maintained a Market Outperform rating on Prothena Corp and raised the price target from $81 to $85.
The increase in price target by JMP Securities, a reputable financial firm, suggests a positive outlook on Prothena Corp's stock. This endorsement is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100